{"id":6094,"date":"2022-07-14T10:28:06","date_gmt":"2022-07-14T15:28:06","guid":{"rendered":"http:\/\/pharmgate.com\/usa\/?page_id=6094"},"modified":"2026-02-19T14:17:32","modified_gmt":"2026-02-19T20:17:32","slug":"tenotryl","status":"publish","type":"page","link":"https:\/\/pharmgate.com\/usa\/tenotryl\/","title":{"rendered":"Tenotryl"},"content":{"rendered":"\n

\n\t\tTenotryl\u00ae<\/sup>\n\t<\/h1>\n\t

(enrofloxacin)
\nInjectable Solution<\/h3>\n\t\t\t\t\"Aivlosin-species-577x75\"\n\t\t\t\n\t\t\t\t\t\tPrescribing Information\n\t\t\t\t\t<\/a>\n\t\t\t\n\t\t\t\t\t\tProduct Profile Sheet\n\t\t\t\t\t<\/a>\n\t\t\t\n\t\t\t\t\t\tSafety Data Sheet\n\t\t\t\t\t<\/a>\n\t\t\t\n\t\t\t\t\t\tTenotryl Info\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t

Product Description<\/h4>\n\t\t\t

Tenotryl\u2122 (enrofloxacin) injectable solution is indicated for the treatment and control of swine respiratory disease (SRD) associated with\u00a0Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica\u00a0<\/em>and\u00a0Mycoplasma hyopneumoniae.<\/em><\/p>\n

Tenotryl\u2122 (enrofloxacin) injectable solution is also indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with\u00a0Escherichia coli<\/em>\u00a0has been diagnosed.<\/p>\n\t\t\t\t\t\t

Key Features<\/h4>\n

Swine:<\/strong><\/p>\nTarget seven bacterial pathogens\u00a0<\/strong>with a single injection
\n<\/strong>Enrofloxacin, the active ingredient in Tenotryl\u2122 injectable solution is an efficient, broad-spectrum antibiotic that has been trusted in the U.S. swine industry for 25 years. A convenient, single-dose injection delivers swift and broad action against seven bacterial pathogens that cause swine respiratory disease (SRD), as well as colibacillosis associated with\u00a0E. coli<\/em>.\nKills key bacterial SRD pathogens and\u00a0E. Coli
\n<\/em><\/strong>Tenotryl\u2122 injectable solution possesses the activity needed to kill most of the primary SRD pathogens and\u00a0E. coli<\/em>. Enrofloxacin is a broad-spectrum antibiotic with low minimal inhibitory concentration (MIC) on the primary agents of SRD and colibacillosis associated with\u00a0E. coli<\/em>. Its bactericidal effects are concentration or time-dependent.1<\/sup>\n

\"\"<\/p>\n

1 Gigu\u00e9re, S.; Prescot, J.F.; Dowling, P.M. 2013. Antimicrobial Therapy in Veterinary Medicine, Fifth Edition.<\/em><\/p>\n\n\t\t\t\t\t\t

Label Indications and Dosage<\/h4>\n\t\t\t
\n\t
\n\t\t\r\n
\r\n\t\t
\r\n\t\t
\r\n\t\t\t
<\/i><\/div>\t\t\t
Swine<\/div>\r\n\t\t\t\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\n
\n
\n
\n
\n
\n
\n

Indications:
\n<\/strong>Tenotryl\u2122 (enrofloxacin) injectable solution is indicated for the treatment of swine respiratory disease (SRD) associated with\u00a0Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica,\u00a0<\/em>and\u00a0Mycoplasma hyopneumoniae<\/em>. It is also indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with\u00a0Escherichia coli<\/em>\u00a0has been diagnosed. To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line drug for colibacillosis in swine following consideration of other therapeutic options.<\/p>\n

Dosage\/Administration:
\n<\/strong>(SRD Treatment):<\/strong>\u00a0Administer, by intramuscular or subcutaneous (behind the ear) injection, a single dose of 7.5 mg\/kg of body weight (3.4 mL\/100 lbs.). Administered dose volume should not exceed 5 mL per injection site.<\/p>\n

(Colibacillosis Control):<\/strong>\u00a0Initiate administration within the first 60 days post-weaning when clinical signs are present in at least 2% of animals in the group. Administer, either by intramuscular or subcutaneous (behind the ear) injection, a single dose of 7.5 mg\/kg of body weight (3.4 mL\/100 lbs.). Administered dose volume should not exceed 5 mL per injection site.\u00a0If no improvement is noted within 48 hours, the diagnosis should be reevaluated.
\n\"\"\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n

<\/h4>\n<\/div>\n<\/div>\n\t\t<\/div>\r\n\t<\/div>\r\n\t<\/div>\r\n\t<\/div>\n<\/div>\n<\/div>
<\/div>\t\t\n\t\t\t\t\t\t

Withdrawal Period and Safety<\/h4>\n\t\t\t

Animals intended for human consumption must not be slaughtered within 5 days of receiving a single-injection dose.<\/p>\n

The effects of enrofloxacin on swine reproductive performance, pregnancy, and lactation have not been adequately determined. The long-term effects on articular joint cartilage have not been determined in pigs above market weight.<\/p>\n\t\t\t\t\t\t

Packaging<\/h4>\n\t\t\t